References, presentations and materials

Presentations from meetings

A list of reports, briefings and presentations from UK CAB meetings.

This includes PowerPoints and PDFs hosted on this website and selected additional materials hosted on eternal websites. All of these have been presented or discussed at UK CAB meetings.

CROI 2010 feedback: Simon Collins, 172 Kb, 2010
Poster: Africans in UK present late and are likely to be on ARVs soon after an HIV diagnosis: Dr Getrude Wafula-Anyango, 2.2 MB, 2010
HIV and MSM in England: A new wave of challenge: Adebisi Alimi, 452 Kb, 2010
African sub-groups session Issues for Men:: Jabulani Chwaula, 1.2 MB, 2010
African Treatment Issues and HPA data on late diagnosis: Dr Ade Fakoya, 1.2 MB, 2010
Feedback from BHIVA Conference: Robert James, 56 Kb, 2009
Ageing with HIV: Project overview Frontline HIV Forum: John J.J. O'Callaghan-Williamson, 2.1 MB. 2009
Proposed Ageing Study: Caroline Sabin, 720 Kb, 2009
IAS Feedback Cape Town 2009: Simon Collins, 3.2 Mb, 2009
BMS Data Update: Dr Keith Aizen, Victoria Adamson BMS, 3.3 Mb, 2009
Advocacy Training in Practice: Winnie Sseruma, 564 Kb, 2009
HIV Treatment Advocacy Overview: Michael Marr , 948 Kb, 2009
Draft BHIVA Guidelines Routine Monitoring of HIV: Matthew Williams, 948 Kb, 2009
BHIVA feedback: Simon Collins, 844 Kb, 2009
Feedback from CROI - BHIVA: Simon Collins, 72 Kb, 2009
HIV and Drug Resistance: Simon Collins, 2.2 Mb, 2009
Introducing the HIV Vaccine Advisory Board: Ken Legg, 556 Kb, 2009
When to Start Therapy? The Patient's Viewpoint: Gus Cairns, 1.6 Mb, 2009
A rough guide to the immune system: Dr Adrian Palfreeman, 1.1 Mb, 2009
Intelence (Etravirine) Update: Rekha Sinha, MD, 1.7Mb, 2009
TMC278 Update: Peter Williams, 888 Kb, 2009
TMC207 Update: Karel de Beule, 364 Kb, 2009
Etravirine, Darunavir and pipeline HIV plus HCV and TB: Tibotec, 876 Kb, 2009
Overview: Tibotec, 3.1 Mb, 2009
Mexico feedback: research overview PDF: Simon Collins, HIV i-Base, 1.2 Mb, 2008
Mexico feedback: social issues PDF: Paul Clift, UK-CAB, 1 Mb, CAB 27, 2008
BHIVA/CHIVA feedback Powerpoint: Matt Williams, UK-CAB, 369 Kb, 2008
Young people and HIV: a social support perspective PDF: Maria Phelan, NCB, 256 Kb, Oct 2008

Undetectable = uninfectious? Treatment as prevention PowerPoint: Dr Bernard Hirschel, University Hospital, Geneva, 232 Kb, 2008
Undetectable = uninfectious? Community response PowerPoint: Edwin J Bernard, NAM, 375 Kb, 2008
Undetectable = uninfectious? Community response PowerPoint: Silvia Petretti, Positively Women/PozFem UK, 245 Kb, 2008
Guidance for public on reporting side effects PDF (external link): MRHA, 65 Kb, 2008
10 essential actions for effective TB infection control PDF (external link): Stop TB Partnership, 231 Kb, 2008
Describing the risk of an event and identifying risk factors PowerPoint: 336 Kb, Dr Caroline Sabin, Royal Free Hospital, 2008
CROI 2008 feedback: understanding statistics in 3 studies PDF: 4 Mb, Simon Collins, HIV i-Base, 2008
D:A:D position statement - abacavir, ddI and risk of heart attack PDF (external link): 63 Kb, D:A:D steering committee, 2008
Immigration removal centres and HIV PowerPoint: 214 Kb, Joe Murry, Policy Officer, NAT, 2007
Tests and monitoring in HIV infection PowerPoint: 558 Kb, Matt Williams, UK CAB, 2007
Viral tropism PowerPoint: 592 Kb, Matt Williams, UK CAB, 2007
Monitoring HIV infection and treatment in the era of HAART PowerPoint: 152 Kb, Dr Simon Edwards, Mortimer Market Centre, 2007
Sisters are doing it for themselves: women, sexual health and HIV PDF (external link): 1.5 Mb, HIV Scotland, 2007
BHIVA Audit 2006-7: survey of patient assessment and monitoring PDF (external link): 80 Kb, BHIVA, 2007
Women, HIV and microbicides seminar report PDF (external link): 210 Kb, George House Trust and UK African Microbicides Working Group, 2007
BHIVA standards project PowerPoint: 258 Kb, Hilary Curtis, 2006
Human rights protection for people with HIV/AIDS PowerPoint (external link): 42 Kb, Hermione McEwen, Senior Solicitor, Greater Manchester Immigration Aid Unit, 2006
UK guideline for the use of post-exposure prophylaxis for HIV following sexual exposure PDF (external link): 180 Kb, BASHH (International Journal of STD and AIDS), 2006
Update on the neurological manifestations of HIV PDF (external link): 192 Kb, Justin McArthur, MBBS,MPH, Professor of Neurology and Epidemiology, Johns Hopkins University School of Medicine (PRN Notebook), 2005
CAB steering group feedback PowerPoint: 164 Kb, Mark McPherson, UK CAB, 2005
HIV Clinical trials at MRC Clinical Trials Unit PowerPoint: 1.3 Mb, Nick Paton, MRC Clinical Trials Unit, 2005
Entry inhibitors and immunology PowerPoint: 116 Kb, Simon Collins, HIV i-Base, 2005
Paediatric HIV care PowerPoint: 547 Kb, HIV i-Base, 2005
BHIVA treatment guidelines 2005 PowerPoint: 84 Kb, Simon Collins, HIV i-Base, 2005
BHIVA guidelines: what's new - new drugs PowerPoint: 620 Kb, Brian West, HIV Scotland, 2005
Participating in an HIV vaccine trial PowerPoint: 212 Kb, Jo Robinson, EATG Vaccines Working Group, 2004
HIV vaccine clinical trials: the need for community involvement PowerPoint: 448 Kb, Ken Legg, Imperial College of London, 2004
Community participation in western Europe PowerPoint: 2.1 Mb, Emmanuel Trénado, EATG Vaccines Working Group, 2004
Community participation in eastern Europe PowerPoint: 1.4 Mb, Dmitry Samoylov, Community of People Living with HIV/AIDS, Moscow, 2004
European AIDS vaccine trials: an advocacy agenda: 148 Kb, Marion Zibelli, EATG Vaccine Working Group, 2004
Statistics part 3: design of randomised controlled trials of treatments for HIV infection PowerPoint: 312 Kb, Dr Caroline Sabin, Reader in Medical Statistics and Epidemiology, Department of Primary Care and Population Sciences, 2004
Introduction to basic vaccine technology PowerPoint: 416 Kb, Henry Graeme-Smith, 2004
Topical microbicides PowerPoint: 3.4 Mb, Jo Robinson, THT in cooperation with the Global Campaign for Microbicides, 2004
International AIDS Vaccine Initiative PowerPoint: 1.9 Mb, Maite Suarez, IAVA, 2004
Community involvement in vaccine and microbicide research PowerPoint: 48 Kb, Julian Meldrum, 2004
Thorny issues in HIV vaccine trials PowerPoint: 272 Kb , Saul Walker, Policy Advisor. IAVI, 2004
Towards error-free HIV diagnosis: guidelines on laboratory practice PDF (external link): 332 Kb, JV Parry, PP Mortimer, KR Perry, D Pillay, M Zuckerman, for the Health Protection Agency HIV Laboratory Diagnosis Message board (Communicable Disease and Public Health), December 2003
Statistics part 2: hypothesis (significance) testing - more complex statistical methods PDF: 464 Kb, Dr Caroline Sabin, Reader in Medical Statistics and Epidemiology, Department of Primary Care and Population Sciences, 2003
Statistics part 1: different types of study design - describing and displaying data PDF: 628 Kb, Dr Caroline Sabin, Reader in Medical Statistics and Epidemiology, Department of Primary Care and Population Sciences, 2003
Enfuvirtide (T-20) PowerPoint: 5 Mb, Roche, Leroy Benons, Medical Advisor - HIV, Roche, 2003
Access to HIV treatment: issues of working with HIV positive refugees and asylum seekers PowerPoint: 61 Kb, Linda McDonald MA MSc RN, 2003
TB and HIV PowerPoint: 880 Kb, Dr Anton Pozniak, Chelsea and Westminster Hospital, 2003
Hepatits C/HIV coinfection PDF: 748 Kb, Dr Ranjababu Kulasegaram, Guy's and St Thomas' Hospital, 2003
Principles of care of the HIV-1 infected pregnant mother PowerPoint: 5.1 Mb, Dr Karen Beckerman, Assistant Professor of Obstetrics and Gynaecology, New York University, October 2002
HIV and subfertility PowerPoint: 338 Kb, Leila Frodsham, Clinical Research Fellow, Assisted Conception Unit, Chelsea and Westminster, 2002
Tipranavir: design of the RESIST study PowerPoint: 468 Kb, Dr Kevin Curry, Boehringer Ingelheim, 2002
Unique resistance profile of tipranavir PowerPoint: 696 Kb, Dr Kevin Curry, Boehringer Ingelheim, 2002
Clinical aspects of treatment with tipranavir PowerPoint: 444 Kb, Dr Kevin Curry, Boehringer Ingelheim, 2002
Understanding HIV-1 drug resistance testing PDF: 2.5 Mb, Professor Clive Loveday, International Clinical Virology Centre, 2002
Salvage therapy PDF: 1.1 Mb, Dr Mike Youle, Royal Free Centre for HIV Medicine, 2002
Methods of drug evaluation PowerPoint: 332 Kb, Tim Peto, MRC Clinical Trials Unit, 2002
Gilead: tenofovir PDF: 328 Kb, Gilead Sciences, 2002
Atazanavir PowerPoint: 834 Kb, BMS, 2002
Informed consent and patient involvement in trials PowerPoint: 52 Kb, Norbert Tamm, Research Charge Nurse, Imperial College and St Mary's Hospital, 2002
d4T (stavudine, Zerit) extended release PowerPoint: 166 Kb, BMS, 2002
DPC 083-201 (DuPont 083) PowerPoint: 914 Kb, Dr Nancy Ruiz, 2002

Updated: 1 November 2008